Publisher Correction: European Radiology

https://doi.org/10.1007/s00330-023-10222-0

In the Graphical Abstract, the clinical translational relevance should be: “The alpha-RECIST and National Cancer Center strategy are optimal methods for determining therapeutic response to a combination of anti-angiogenic therapy plus immunotherapy and facilitating accurate prognostic stratification for HCC in the AFP ≥ 20 ng/mL group and the whole cohort, which may help oncologists for early identification of responders and progression at 6 weeks and clinical decision-making.” Value “20” was incorrectly deleted in typesetting.

The corrected Graphical Abstract is as can be seen below:

figure a

The original article has been corrected.